Creative Medical Technology Stock Current Liabilities
| CELZ Stock | USD 1.96 0.12 6.52% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Creative Medical's long-term financial health and intrinsic value.
Total Current Liabilities is expected to decline to about 311.3 K this year. Non Current Liabilities Total is expected to grow at the current pace this year. Creative | Current Liabilities | Build AI portfolio with Creative Stock |
Creative Medical Technology Company Current Liabilities Analysis
Creative Medical's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Creative Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Creative Medical is extremely important. It helps to project a fair market value of Creative Stock properly, considering its historical fundamentals such as Current Liabilities. Since Creative Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Creative Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Creative Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
Creative Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Creative Medical Technology has a Current Liabilities of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Creative Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Creative Medical's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Creative Medical could also be used in its relative valuation, which is a method of valuing Creative Medical by comparing valuation metrics of similar companies.Creative Medical is currently under evaluation in current liabilities category among its peers.
Creative Fundamentals
| Return On Equity | -0.98 | ||||
| Return On Asset | -0.6 | ||||
| Current Valuation | 1.05 M | ||||
| Shares Outstanding | 3.49 M | ||||
| Shares Owned By Insiders | 1.00 % | ||||
| Shares Owned By Institutions | 5.90 % | ||||
| Number Of Shares Shorted | 77.02 K | ||||
| Price To Earning | (54.81) X | ||||
| Price To Book | 1.15 X | ||||
| Price To Sales | 1,072 X | ||||
| Revenue | 11 K | ||||
| Gross Profit | 3.6 K | ||||
| EBITDA | (5.63 M) | ||||
| Net Income | (5.49 M) | ||||
| Cash And Equivalents | 22.86 M | ||||
| Cash Per Share | 1.62 X | ||||
| Total Debt | 14.19 K | ||||
| Current Ratio | 58.88 X | ||||
| Book Value Per Share | 2.17 X | ||||
| Cash Flow From Operations | (5.3 M) | ||||
| Short Ratio | 0.80 X | ||||
| Earnings Per Share | (2.84) X | ||||
| Target Price | 20.0 | ||||
| Beta | 5.86 | ||||
| Market Capitalization | 6.43 M | ||||
| Total Asset | 6.67 M | ||||
| Retained Earnings | (64.59 M) | ||||
| Working Capital | 5.81 M | ||||
| Net Asset | 6.67 M |
About Creative Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Creative Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Creative Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Creative Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.